XCancer
Hospitals & Physicians Clinics · Nebraska, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
17607 Gold Plz, Omaha, Nebraska, 68130, ...Phone Number
(402) 991-8468Website
www.xcancer.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About XCancer
XCancer is a consortium of innovative companies dedicated to advancing cancer care through clinical trials, research networks, and novel drug development. Founded by Dr. Luke Nordquist, it has become a recognized leader in prostate cancer care, providing cutting-edge treatments and compassionate support to patients from across the globe. The organization also operates TheranosticTrials.Org, a platform that connects stakeholders in the cancer ecosystem, and offers consulting services to enhance clinical trial development. With a mission to break down barriers to access, XCancer aims to ensure that life-saving innovations reach underserved populations worldwide.Explore more
XCancer Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is XCancer your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once XCancer has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when XCancer launches new products
Check if XCancer has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on XCancer recently announced quarterly report
Check out if XCancer is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at XCancer
Click to see if XCancer had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
XCancer, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
XCancer is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
XCancer is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about XCancer.
XCancer Tech Stack
A closer look at the technologies used by XCancer
XCancer News & Media
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT
SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has...Registrational Phase III AMPLIFY trial in biochemical recurrence of prostate cancer commences
SYDNEY, May 20, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that it has commenced its second registrational Phase III 64Cu-SAR-bisPSMA diagnostic trial in prostate cancer, AMPLIFY (NCT06970847)1, with the initiation of the first clinical site at XCancer in Omaha, NE. AMPLIFY is a studVial welcomes Dr. Luke Nordquist of XCancer and UCC to Vial's Oncology CRO Advisory Board
SAN FRANCISCO, Aug. 3, 2022 /PRNewswire/ -- Vial is welcoming Dr. Luke Nordquist to Vial's Oncology Scientific Advisory Board. Dr. Nordquist is the latest addition to the board after Dr. Arati Rao, Dr. Antoni Ribas, Dr. Arvind Chaudhry, and Dr. Guru Sonpavde joined earlier this year. The...
Read more news
Top Hospitals & Physicians Clinics Companies
Frequently Asked Questions Regarding XCancer
Sign Up For FreeTo access detailed company insights
XCancer is a consortium of innovative companies dedicated to advancing cancer care through clinical trials, research networks, and novel drug development. Founded by Dr. Luke Nordquist, it has become a recognized leader in prostate cancer care, providing cutting-edge treatments and compassionate support to patients from across the globe. The organi... Read More
